Saved in:
| Main Authors: | Inmaculada Hernandez, Sean D. Sullivan |
|---|---|
| Format: | Artículo Open Access |
| Published: |
Wiley
2024
|
| Subjects: | |
| Online Access: | https://onlinelibrary.wiley.com/doi/10.1002/oby.23973 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
Nutritional considerations with antiobesity medications
by: Jaime P. Almandoz, et al.
Published: (2024)
by: Jaime P. Almandoz, et al.
Published: (2024)
Response to “Nutritional considerations with antiobesity medications”
by: Shaminie J. Athinarayanan
Published: (2024)
by: Shaminie J. Athinarayanan
Published: (2024)
Response to “Nutritional considerations with antiobesity medications”
by: Gabriela de Souza Bett, et al.
Published: (2024)
by: Gabriela de Souza Bett, et al.
Published: (2024)
Twelve‐month analysis of real‐world evidence from a telehealth obesity‐treatment provider using antiobesity medications
by: Jamy D. Ard, et al.
Published: (2024)
by: Jamy D. Ard, et al.
Published: (2024)
Adverse event comparison between glucagon‐like peptide‐1 receptor agonists and other antiobesity medications following bariatric surgery
by: Jason M. Samuels, et al.
Published: (2024)
by: Jason M. Samuels, et al.
Published: (2024)
Meta‐analysis and machine learning reveal the antiobesity effects of melatonin on obese rodents
by: Yuying Li, et al.
Published: (2024)
by: Yuying Li, et al.
Published: (2024)
Association of patient characteristics and insurance type with anti‐obesity medications prescribing and fills
by: Hamlet Gasoyan, et al.
Published: (2024)
by: Hamlet Gasoyan, et al.
Published: (2024)
Managing the new wave of weight loss medication in general practice: A qualitative study
by: Pernille Andreassen, et al.
Published: (2024)
by: Pernille Andreassen, et al.
Published: (2024)
Mindful eating and its relationship with body mass index, binge eating, anxiety and negative affect
by: Sheila Pintado-Cucarella
Published: (2016)
by: Sheila Pintado-Cucarella
Published: (2016)
Antiobesity medications in active‐duty military personnel
by: Brandon M. Roberts, et al.
Published: (2024)
by: Brandon M. Roberts, et al.
Published: (2024)
The association between weight loss medications and cardiovascular complications
by: Onur Baser, et al.
Published: (2024)
by: Onur Baser, et al.
Published: (2024)
Weight management medications for chronic use in 37 veterans affairs medical centers—A medication use evaluation
by: Samantha Walczuk, et al.
Published: (2024)
by: Samantha Walczuk, et al.
Published: (2024)
Less frequent dosing of GLP‐1 receptor agonists as a viable weight maintenance strategy
by: Calvin C. Wu, et al.
Published: (2025)
by: Calvin C. Wu, et al.
Published: (2025)
The vices and virtues of medical models of obesity
by: Jonathan Sholl, et al.
Published: (2024)
by: Jonathan Sholl, et al.
Published: (2024)
Global deletion of G protein‐coupled receptor 55 impairs glucose homeostasis during obesity by reducing insulin secretion and β‐cell turnover
by: Bo Liu, et al.
Published: (2024)
by: Bo Liu, et al.
Published: (2024)
Obesity and postpartum hospital use among individuals without additional medical comorbidities
by: Kimberly B. Glazer, et al.
Published: (2024)
by: Kimberly B. Glazer, et al.
Published: (2024)
Measurement and evaluation of community engagement in complex, chronic medical conditions: HIV and obesity as exemplar conditions
by: Andrew D. Brown, et al.
Published: (2025)
by: Andrew D. Brown, et al.
Published: (2025)
Determinants of adherence to obesity medication: A narrative review
by: Arya M. Sharma, et al.
Published: (2025)
by: Arya M. Sharma, et al.
Published: (2025)
The effects of anti‐obesity medications on bone metabolism: A critical appraisal
by: Athanasios D. Anastasilakis, et al.
Published: (2025)
by: Athanasios D. Anastasilakis, et al.
Published: (2025)
Evaluation of prescription medication changes following sleeve gastrectomy surgery
by: Gina Arena, et al.
Published: (2024)
by: Gina Arena, et al.
Published: (2024)
Primary care perspectives on prescribing anti‐obesity medication for adolescents
by: Rutha Chivate, et al.
Published: (2024)
by: Rutha Chivate, et al.
Published: (2024)
Perceptions of anti‐obesity medications among people with obesity and healthcare providers in the US: Findings from the OBSERVE Study
by: Lee M. Kaplan, et al.
Published: (2025)
by: Lee M. Kaplan, et al.
Published: (2025)
Cost‐utility analysis and drug pricing for tirzepatide for type 2 diabetes in the Chinese market compared with semaglutide
by: Shanshan Hu, et al.
Published: (2024)
by: Shanshan Hu, et al.
Published: (2024)
Enfoque de la obesidad infantil desde la pediatría
by: Erika F. Hurtado-López
Published: (2014)
by: Erika F. Hurtado-López
Published: (2014)
Incretin mimetics for weight loss forgive nonadherence
by: Anıl Cengiz, et al.
Published: (2025)
by: Anıl Cengiz, et al.
Published: (2025)
Correction to “Defining diabetes status using medication groups in Medicare data: Trends in prescribing diabetes medications to patients without a diabetes diagnosis over time”
Published: (2024)
Published: (2024)
Ethnic differences in weight loss during a clinical obesity management program
by: Jennifer Linchee Kuk, et al.
Published: (2025)
by: Jennifer Linchee Kuk, et al.
Published: (2025)
The association of weight loss from anti‐obesity medications or bariatric surgery and apnea‐hypopnea index in obstructive sleep apnea
by: Brian W. Locke, et al.
Published: (2024)
by: Brian W. Locke, et al.
Published: (2024)
Comparative safety of glucose‐lowering medications on depression in adults with type 2 diabetes
by: Stephanie A. Hooker, et al.
Published: (2026)
by: Stephanie A. Hooker, et al.
Published: (2026)
Cardiometabolic risk effects of weight‐loss medications: An updated network meta‐analysis
by: Juan Wang, et al.
Published: (2025)
by: Juan Wang, et al.
Published: (2025)
Four‐year follow‐up of weight loss maintenance using electronic medical record data: The PROPEL trial
by: Peter T. Katzmarzyk, et al.
Published: (2024)
by: Peter T. Katzmarzyk, et al.
Published: (2024)
Antidiabetic and lipid‐lowering medication use inversely linked with serum biomarkers of liver fibrosis
by: Jun Wang, et al.
Published: (2025)
by: Jun Wang, et al.
Published: (2025)
What is known about the use of weight loss medication in women with overweight/obesity on fertility and reproductive health outcomes? A scoping review
by: Kate Maslin, et al.
Published: (2024)
by: Kate Maslin, et al.
Published: (2024)
Long‐term adherence to glucose‐lowering medications in adults with diabetes: A data linkage study
by: Crystal M. Y. Lee, et al.
Published: (2025)
by: Crystal M. Y. Lee, et al.
Published: (2025)
The real‐world relationship between naltrexone/bupropion treatment and weight loss in Canada: A retrospective chart review
by: Sean Wharton, et al.
Published: (2024)
by: Sean Wharton, et al.
Published: (2024)
Associations of BMI, sleep quality, and sleep duration trajectories with new‐onset diabetes mellitus in the elderly
by: Shanshan Li, et al.
Published: (2025)
by: Shanshan Li, et al.
Published: (2025)
Tirzepatide for the Maintenance of Body Weight Reduction: Rationale, Design, and Baseline Characteristics of SURMOUNT‐MAINTAIN
by: Deborah B. Horn, et al.
Published: (2025)
by: Deborah B. Horn, et al.
Published: (2025)
Identifying individuals at risk for weight gain using machine learning in electronic medical records from the United States
by: Casey Choong, et al.
Published: (2025)
by: Casey Choong, et al.
Published: (2025)
The association of motivational factors with weight loss and treatment time in a publicly funded weight management clinic
by: Amir Yazdanparast, et al.
Published: (2025)
by: Amir Yazdanparast, et al.
Published: (2025)
Weight status of children and adolescents with autism spectrum disorder: A cross‐sectional analysis of primary care electronic medical records and linked health administrative datasets in Ontario, Canada
by: Laura M. Kinlin, et al.
Published: (2025)
by: Laura M. Kinlin, et al.
Published: (2025)
Similar Items
-
Nutritional considerations with antiobesity medications
by: Jaime P. Almandoz, et al.
Published: (2024) -
Response to “Nutritional considerations with antiobesity medications”
by: Shaminie J. Athinarayanan
Published: (2024) -
Response to “Nutritional considerations with antiobesity medications”
by: Gabriela de Souza Bett, et al.
Published: (2024) -
Twelve‐month analysis of real‐world evidence from a telehealth obesity‐treatment provider using antiobesity medications
by: Jamy D. Ard, et al.
Published: (2024) -
Adverse event comparison between glucagon‐like peptide‐1 receptor agonists and other antiobesity medications following bariatric surgery
by: Jason M. Samuels, et al.
Published: (2024)